Is Moderna and NIH Partnership “Rotten To The Core”?

By  |  0 Comments

from Ben Swann:

Is Moderna and NIH Partnership “Rotten To The Core”?


Ben Swann takes a look at the highly unusual timeline by which Moderna Therapeutics is developing its C0-vId 19 virus vaccine. Now, 4 scientists with the NIH claim they hold partial patent rights on that vaccine and stand to make up to $150,000 per year. Meanwhile, as Moderna’s stock price continues to soar, 5 top executives have sold off $89 million dollars worth of shares, even as the company continues to bypass standard vaccine protocols in the development of its C0-vId v@ccine


More from Ben…

Ghislane Maxwell Arrested by FBI! Is She The Center of The Entire Epstein Case?


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.